Marina Parra-Robert

Marina Parra-Robert

Auto-generated profile, based on publicly available information

Marina Parra-Robert

Pharmacology and Toxicology Laboratory, Department of Clinical Biochemistry and Molecular Genetics, CDB, Hospital Clínic de Barcelona

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2023 in Science Translational Medicine
Verified
Journal Article
Closed access
AMAlazne Moreno-Lanceta
Alazne Moreno-Lanceta
MMMireia Medrano-Bosch
Mireia Medrano-Bosch
YFYiliam Fundora-Suárez
Yiliam Fundora-Suárez
MPMeritxell Perramón
Meritxell Perramón
JAJessica Aspas
Jessica Aspas
PMPedro Melgar-Lesmes
Pedro Melgar-Lesmes
Hepatic inflammation is a common trigger of chronic liver disease. Macrophage activation is a predictive parameter for survival in patients with cirrhosis. Ring finger protein 41 (RNF41) negatively regulates proinflammatory cytokines and receptors; however, the precise involvement of macrophage RNF41 in liver cirrhosis remains unknown. Here, we sought to understand how RNF41 dictates macrophage fate in hepatic fibrosis and repair within the inflammatory milieu. We found that RNF41 expression is down-regulated in CD11b + macrophages recruited to mouse fibrotic liver and to patient cirrhotic liver regardless of cirrhosis etiology. Prolonged inflammation with TNF-α progressively reduced macrophage RNF41 expression. We designed a macrophage-selective gene therapy with dendrimer-graphite nanoparticles (DGNPs) to explore the influence of macrophage RNF41 restoration and depletion in liver fibrosis and regeneration. RNF41 expression induced in CD11b + macrophages by DGNP-conjugated plasmids ameliorated liver fibrosis, reduced liver injury, and stimulated hepatic regeneration in fibrotic mice with or without hepatectomy. This therapeutic effect was mainly mediated by the induction of insulin-like growth factor 1. Conversely, depletion of macrophage RNF41 worsened inflammation, fibrosis, hepatic damage, and survival. Our data reveal implications of macrophage RNF41 in the control of hepatic inflammation, fibrosis, and regeneration and provide a rationale for therapeutic strategies in chronic liver disease and potentially other diseases characterized by inflammation and fibrosis.

2 July 2025 in Scandinavian Journal of Clinical and Laboratory Investigation
Verified
Journal Article
Closed access
JLJavier Laguna
Javier Laguna
RWRobin Wijngaard
Robin Wijngaard
LMLourdes Marés
Lourdes Marés
MPMarina Parra-Robert
Marina Parra-Robert
GCGregori Casals
Gregori Casals
JTJordi To-Figueras
Jordi To-Figueras
The biochemical diagnosis of porphyria is based on the analysis of porphyrins in urine, feces, and blood using fluorometry and spectrometry. High-performance liquid chromatography (HPLC) with fluorescence detection has been used since the 1980s as standard procedure for separation of porphyrin isomers and classification of the different types of porphyria since each type of porphyria presents a characteristic HPLC isomer distribution either in urine, plasma or feces. We present a unified collection of chromatograms as an aid for porphyria classification in laboratories using HPLC equipment. Biological samples were collected according to approved hospital protocols, and analyzed by reverse-phase HPLC with fluorescence detection, using an unused dedicated chromatographic column BDS-Hypersil™ C18 and reproducing, with minor variations, the conditions originally reported by Lim and Peters in 1984. With the chromatograms, we include a concise explanation of the changes observed. When inter-individual variation is frequent, we include for clarification chromatograms of two different individual samples. Additionally, we present chromatograms showing abnormalities of porphyrin metabolism in patients without porphyria. We add our collection to the literature, as a visual guide to facilitate porphyria diagnosis and classification though understanding of the key metabolic changes. Our aim is to support education of new experts in the porphyria field increasing diagnostic accuracy and ultimately leading to improved patient outcomes and management.

2 September 2023 in Clinical Toxicology
Verified
Journal Article
Closed access
AEAlba Escolà-Rodríguez
Alba Escolà-Rodríguez
MPMarina Parra-Robert
Marina Parra-Robert
DCDaniel Carrasco-Gómez
Daniel Carrasco-Gómez
TETeresa Escartín-Díez
Teresa Escartín-Díez
ABAleix Borja Fabregat Bolufer
Aleix Borja Fabregat Bolufer

27 June 2026 in Scandinavian Journal of Clinical and Laboratory Investigation
Verified
Journal Article
Closed access
NSNerea Sainz-Pastor
Nerea Sainz-Pastor
EMEdgar Martín
Edgar Martín
EJEstel Julià
Estel Julià
LSLoredana Cosmina Sabau
Loredana Cosmina Sabau
ENElías Navas
Elías Navas
MPMarina Parra-Robert
Marina Parra-Robert
Urine drug screening is a valuable diagnostic tool for assessing acute intoxications in the emergency department. Enzyme immunoassay (IA) and immunochromatography (IC) are the two main techniques routinely used due to their rapid turnaround, low cost, and high sensitivity. However, results must be interpreted with caution, as structural cross-reactivity may cause false-positive (FP) findings. We retrospectively analyzed 55 urine samples from emergency patients initially screened for amphetamines by IA and confirmed by gas chromatography-mass spectrometry (GC-MS). Samples containing amphetamine derivatives or potentially cross-reactive substances (tetracaine, trazodone, methylphenidate, ritalinic acid, phentermine, procainamide, ephedrine, bisoprolol, and synthetic cathinones) were subsequently analyzed using an IC assay. Diagnostic performance and cross-reactivity were compared between both screening methods. Of the 55 samples selected by IA, 34 were true positives (TP), 8 true negatives (TN), 2 false negatives (FN), and 11 FP. FP by IA were mainly due to tetracaine, trazodone, phentermine, ephedrine, and procainamide. In comparison, IC yielded 32 TP, 17 TN, 2 FP (phentermine and bisoprolol), and 4 FN. No cross-reactivity with methylphenidate and synthetic cathinones was observed in either technique. IC showed frequent misclassifications between amphetamine and methamphetamine while MDMA detection was more specific. IC is a reliable and rapid alternative for amphetamine screening in the emergency setting, providing improved specificity and fewer false positives than IA. Given its limited discrimination between amphetamine and methamphetamine, IC results should be reported as 'amphetamine derivatives'. These findings highlight assay-dependent cross-reactivity and the importance of understanding methodological limitations for an accurate interpretation.

1 November 2015 in Medicina Clinica
Verified
Journal Article
Closed access
SNSantiago Nogué
Santiago Nogué
MGMiguel Galicia
Miguel Galicia
MPMarina Parra
Marina Parra
JTJordi To-Figueras
Jordi To-Figueras